Bupropion as a Possible Treatment for COVID-19-Related Brain Fog

Jessica George ’24 The COVID-19 pandemic has affected millions of people worldwide, and many have reported persistent symptoms even after recovery from the initial infection. One of the most common long-term symptoms reported is “brain fog,” a condition characterized by cognitive impairments such as memory loss, difficulty concentrating, and mental fatigue. A recent case series published by Dr. Samuel Reinfeld from the Stony Brook University … Continue reading Bupropion as a Possible Treatment for COVID-19-Related Brain Fog

Nationwide RCT Single Session Interventions on Depression in Adolescents: COVID-19 edition

Daphne Siozios ’23 Once the coronavirus pandemic emerged, distress due to isolation caused an immediate surge in adolescent depression. While depression in youths was already regarded as the biggest psychosocial adversity prior to COVID-19, newfound disruption of social-emotional support because of direct seclusion resulting from the pandemic has led to elevated depression. By observing randomized controlled trials of brief, scalable interventions, it has been said … Continue reading Nationwide RCT Single Session Interventions on Depression in Adolescents: COVID-19 edition

Uncovering the Link Between SARS-CoV-2 and Vascular Dysregulation

Alex Moir ’23 SARS-CoV-2 is the virus currently driving the COVID-19 pandemic. SARS-CoV-2 has been shown to infect ciliated epithelial cells (EPCs), which line the upper respiratory tract, through a cell surface receptor known as angiotensin-converting enzyme 2 (ACE2), resulting in Acute Respiratory Distress Syndrome (ARDS). ARDS is characterized by both pulmonary and vascular dysregulation, which presents as shortness of breath, low oxygen, and poor … Continue reading Uncovering the Link Between SARS-CoV-2 and Vascular Dysregulation